Hacker News new | past | comments | ask | show | jobs | submit login

Why do all the new cancer drugs coming out end in the letter "B"?



Its a side-effect of the naming convention for generic drug naming [1]. Small molecule inhibitors end with “ib”. Monoclonal antibodies end with “mab”. Etc.

[1] https://en.wikipedia.org/wiki/Drug_nomenclature


I think the *mab ones are monoclonal antibodies, and the *nib ones are inhibitors. I don't think it's a hard rule though.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: